215 related articles for article (PubMed ID: 20521961)
21. [Clostridium difficile-associated diarrhea--an increasing problem. Reduce the administration of antibiotics and improve hygiene!].
Svenungsson B
Lakartidningen; 1996 Aug; 93(35):2931-4. PubMed ID: 8815352
[No Abstract] [Full Text] [Related]
22. Reexamining methods and messaging for hand hygiene in the era of increasing Clostridium difficile colonization and infection.
Ellingson K; McDonald C
Infect Control Hosp Epidemiol; 2010 Jun; 31(6):571-3. PubMed ID: 20429660
[No Abstract] [Full Text] [Related]
23. Evaluation of a sporicidal peracetic acid/hydrogen peroxide-based daily disinfectant cleaner.
Deshpande A; Mana TS; Cadnum JL; Jencson AC; Sitzlar B; Fertelli D; Hurless K; Kundrapu S; Sunkesula VC; Donskey CJ
Infect Control Hosp Epidemiol; 2014 Nov; 35(11):1414-6. PubMed ID: 25333438
[TBL] [Abstract][Full Text] [Related]
24. Use of hypochlorite solution to decrease rates of Clostridium difficile-associated diarrhea.
McMullen KM; Zack J; Coopersmith CM; Kollef M; Dubberke E; Warren DK
Infect Control Hosp Epidemiol; 2007 Feb; 28(2):205-7. PubMed ID: 17265404
[TBL] [Abstract][Full Text] [Related]
25. Synergistic efficacy of 405 nm light and chlorinated disinfectants for the enhanced decontamination of Clostridium difficile spores.
Moorhead S; Maclean M; Coia JE; MacGregor SJ; Anderson JG
Anaerobe; 2016 Feb; 37():72-7. PubMed ID: 26708703
[TBL] [Abstract][Full Text] [Related]
26. Reduction in Clostridium difficile infection associated with the introduction of hydrogen peroxide vapour automated room disinfection.
McCord J; Prewitt M; Dyakova E; Mookerjee S; Otter JA
J Hosp Infect; 2016 Oct; 94(2):185-7. PubMed ID: 27372150
[TBL] [Abstract][Full Text] [Related]
27. [A new virulent clone of Clostridium difficile is a challenge for Danish hospitals].
Schønheyder HC; Kristensen B
Ugeskr Laeger; 2009 May; 171(19):1578. PubMed ID: 19419636
[No Abstract] [Full Text] [Related]
28. Impact of environmental decontamination using hydrogen peroxide vapour on the incidence of Clostridium difficile infection in one hospital Trust.
Cooper T; O'Leary M; Yezli S; Otter JA
J Hosp Infect; 2011 Jul; 78(3):238-40. PubMed ID: 21392849
[No Abstract] [Full Text] [Related]
29. Effect of Variation in Test Methods on Performance of Ultraviolet-C Radiation Room Decontamination.
Cadnum JL; Tomas ME; Sankar T; Jencson A; Mathew JI; Kundrapu S; Donskey CJ
Infect Control Hosp Epidemiol; 2016 May; 37(5):555-60. PubMed ID: 26809607
[TBL] [Abstract][Full Text] [Related]
30. Environmental control to reduce transmission of Clostridium difficile.
Mayfield JL; Leet T; Miller J; Mundy LM
Clin Infect Dis; 2000 Oct; 31(4):995-1000. PubMed ID: 11049782
[TBL] [Abstract][Full Text] [Related]
31. Identification of Clostridium difficile Reservoirs in The Patient Environment and Efficacy of Aerial Hydrogen Peroxide Decontamination.
Yui S; Ali S; Muzslay M; Jeanes A; Wilson APR
Infect Control Hosp Epidemiol; 2017 Dec; 38(12):1487-1492. PubMed ID: 29143704
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the microbiological efficacy of hydrogen peroxide vapor and ultraviolet light processes for room decontamination.
Havill NL; Moore BA; Boyce JM
Infect Control Hosp Epidemiol; 2012 May; 33(5):507-12. PubMed ID: 22476278
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of sporicidal activities of selected environmental surface disinfectants: carrier tests with the spores of Clostridium difficile and its surrogates.
Omidbakhsh N
Am J Infect Control; 2010 Nov; 38(9):718-22. PubMed ID: 21034981
[TBL] [Abstract][Full Text] [Related]
34. Utility of an adenosine triphosphate bioluminescence assay to evaluate disinfection of Clostridium difficile isolation rooms.
Deshpande A; Sitzlar B; Fertelli D; Kundrapu S; Sunkesula VC; Ray AJ; Donskey CJ
Infect Control Hosp Epidemiol; 2013 Aug; 34(8):865-7. PubMed ID: 23838235
[No Abstract] [Full Text] [Related]
35. Activity of Hospital Disinfectants against Vegetative Cells and Spores of Clostridioides difficile Embedded in Biofilms.
Rashid T; Haghighi F; Hasan I; Bassères E; Alam MJ; Sharma SV; Lai D; DuPont HL; Garey KW
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611365
[No Abstract] [Full Text] [Related]
36. Infection control measures to limit the spread of Clostridium difficile. Introduction.
Riley TV; Huovinen P
Clin Microbiol Infect; 2008 May; 14 Suppl 5():1. PubMed ID: 18412709
[No Abstract] [Full Text] [Related]
37. Antimicrobial Stewardship and Environmental Decontamination for the Control of Clostridium difficile Transmission in Healthcare Settings.
Bintz J; Lenhart S; Lanzas C
Bull Math Biol; 2017 Jan; 79(1):36-62. PubMed ID: 27826877
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of an automated room decontamination device using aerosolized peracetic acid.
Mana TS; Sitzlar B; Cadnum JL; Jencson AL; Koganti S; Donskey CJ
Am J Infect Control; 2017 Mar; 45(3):327-329. PubMed ID: 27866755
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of dilute hydrogen peroxide technology for continuous room decontamination of multidrug-resistant organisms.
Rutala WA; Kanamori H; Gergen MF; Sickbert-Bennett EE; Anderson DJ; Sexton DJ; Weber DJ;
Infect Control Hosp Epidemiol; 2019 Dec; 40(12):1438-1439. PubMed ID: 31576788
[No Abstract] [Full Text] [Related]
40. Clostridium difficile: improving the prevention paradigm in healthcare settings.
Vassallo A; Tran MC; Goldstein EJ
Expert Rev Anti Infect Ther; 2014 Sep; 12(9):1087-102. PubMed ID: 25109301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
